Design, synthesis and in vitro evaluation of (R)-4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenyl hydrogen phenylboronate: A novel salbutamol derivative with high intrinsic efficacy on the β2 adrenoceptor-Reference-Cited by-同舟云学术

Design, synthesis and in vitro evaluation of (R)-4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenyl hydrogen phenylboronate: A novel salbutamol derivative with high intrinsic efficacy on the β2 adrenoceptor

Published:2010-10 Issue:19 Volume:20 Page:5623-5629
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Soriano-Ursúa Marvin A.,Correa-Basurto José,Valencia-Hernández Ignacio,Amezcua-Gutiérrez Marcos A.,Padilla-Martínez Itzia I.,Trujillo-Ferrara José G.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference37 articles.

1. Molecular mechanisms of β2-adrenergic receptor function, response, and regulation

2. Activation of β2-adrenergic receptor stimulates γ-secretase activity and accelerates amyloid plaque formation

3. β-Agonists and metabolism

4. 2-Adrenoceptor Activation Attenuates Endotoxin-Induced Acute Renal Failure

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. INVESTIGATION OF THE STRUCTURES OF CLINICALLY IMPORTANT CATECHOLAMINES AND THEIR DERIVATIVES;Ankara Universitesi Eczacilik Fakultesi Dergisi;2023-11-30

2. Advances in Theoretical Studies on the Design of Single Boron Atom Compounds;Current Pharmaceutical Design;2018-12-08

3. Cell-based assays and molecular dynamics analysis of a boron-containing agonist with different profiles of binding to human and guinea pig beta2 adrenoceptors;European Biophysics Journal;2018-11-01

4. Design, synthesis and in vitro evaluation of a Dopa-organoboron compound that acts as a bladder relaxant through non-catecholamine receptors;Molecular Diversity;2018-10-03

5. Molecular Docking and Drug Discovery in β-Adrenergic Receptors;Current Medicinal Chemistry;2017-12-21